🇦🇺 Australia Country × Condition
obesity Clinical Trials in Australia
Active clinical trials for obesity with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia
Active Trials in Australia (3)
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Enrollment
12,800 pts
Country
🇦🇺 Australia
Amgen
View Trial → NCT07225686 Phase 3
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
Enrollment
250 pts
Country
🇦🇺 Australia
Amgen
View Trial → NCT05394363
Recruiting
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Enrollment
150,000 pts
Country
🇦🇺 Australia
Murdoch Childrens Research Institut...
View Trial → Frequently Asked Questions
How many obesity clinical trials are active in Australia?
There are currently 3 active clinical trials for obesity with sites in Australia, of which 3 are actively recruiting patients.
How can I join a obesity clinical trial in Australia?
To join a obesity clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are obesity trials in Australia?
Active obesity trials in Australia span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.